Cite
HARVARD Citation
Radford-Smith, D. et al. (n.d.). P198 An inflammatory serum metabolomic signature predicts response to vedolizumab treatment in people with Crohn's Disease. Journal of Crohn's and colitis. pp. i257-i259. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Radford-Smith, D. et al. (n.d.). P198 An inflammatory serum metabolomic signature predicts response to vedolizumab treatment in people with Crohn's Disease. Journal of Crohn's and colitis. pp. i257-i259. [Online].